Free Access
Issue
J Extra Corpor Technol
Volume 39, Number 2, June 2007
Page(s) 71 - 74
DOI https://doi.org/10.1051/ject/200739071
Published online 15 June 2007
  1. Searles B, Gunst G, Terry B, et al. 2004 Survey of ECMO in the neonate after open heart surgery: Circuitry and team roles. J Extra Corpor Technol. 2005;37:351–4. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  2. Groom RC, Froebe S, Martin J, et al. Update on pediatric perfusion practice in North America: 2005 survey. J Extra Corpor Technol. 2005;37:343–50. [Google Scholar]
  3. Lawson DS, Walczak R, Lawson A, et al. North American neonatal extracorporeal membrane oxygenation (ECMO) devices: 2002 survey results. J Extra Corpor Technol. 2004;36:16–21. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Walczak R, Lawson DS, Kaemmer D, et al. Evaluation of a preprimed microporous hollow-fiber membrane for rapid response neonatal extracorporeal membrane oxygenation. Perfusion. 2005;20:269–75. [CrossRef] [PubMed] [Google Scholar]
  5. Gu YJ, Boonstra PW, Graaff R, et al. Pressure drop, shear stress, and activation of leukocytes during cardiopulmonary bypass: A comparison between hollow fiber and flat sheet membrane oxygenators. Artif Organs. 2000;24:43–8. [CrossRef] [PubMed] [Google Scholar]
  6. Stammers AH, Christensen KA, Lynch J, et al. Quantitative evaluation of heparin-coated versus non-heparin coated bypass circuits during cardiopulmonary bypass. J Extra Corpor Technol. 1999;31:135–41. [Google Scholar]
  7. Ozawa T, Yoshihara K, Koyama N, et al. Clinical efficacy of heparinbonded bypass circuits related to cytokine responses in children. Ann Thorac Surg. 2000;69:584–90. [CrossRef] [Google Scholar]
  8. Pappalardo F, Valle PD, Crescenzi G, et al. Phosphorylcholine coating may limit thrombin formation during high-risk cardiac surgery: A randomized controlled trial. Ann Thorac Surg. 2006;81:886–91. [CrossRef] [Google Scholar]
  9. De Somer F, Francois K, van Oeveren W, et al. Phosphorylcholine coating of extracorporeal circuits provides natural protection against blood activation by the material surface. Eur J Cardiothorac Surg. 2000;18:602–6. [CrossRef] [PubMed] [Google Scholar]
  10. De Somer F, Van Belleghem Y, Caes F, et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass. Perfusion. 2002;17:39–44. [CrossRef] [PubMed] [Google Scholar]
  11. Blumberg N, Triulzi D, Heal J. Transfusion-induced immunomodulation and its clinical consequences. Transfus Med Rev. 1990;4(Suppl 1):24–35. [CrossRef] [Google Scholar]
  12. Murphy PJ, Connery C, Hicks GLJr, et al. Homologous blood transfusion as a risk factor for postoperative infection after coronary artery bypass graft operations. J Thorac Cardiovasc Surg. 1992;104:1092–9. [CrossRef] [Google Scholar]
  13. Spiess BD. Blood conservation: Why bother? J Cardiothorac Vasc Anesth. 2004;18(4 Suppl):1S–5S. [Google Scholar]
  14. Khoshbin E, Westrope C, Pooboni S, et al. Performance of polymethyl pentene oxygenators for neonatal extracorporeal membrane oxygenation: A comparison with silicone membrane oxygenators. Perfusion. 2005;20:129–34. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.